Patents-Review.com
ClassID:

96502 ⎘

C07J7/0045 - CPC Classification

Classification description:

Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16

Recent Application in this class:
#1
20230265121
2023-08-24

CONJUGATED NEUROACTIVE STEROID COMPOSITIONS AND METHODS OF USE

 #2
20220340614
2022-10-27

CONJUGATED NEUROACTIVE STEROID COMPOSITIONS AND METHODS OF USE

 #3
20220153776
2022-05-19

ANTAGONISTS OF CB1 RECEPTOR

 #4
20210230211
2021-07-29

3-(4'-SUBSTITUTED)-BENZYL-ETHER DERIVATIVES OF PREGNENOLONE

 #5
20210115084
2021-04-22

Industrial process for the synthesis of nomegestrol-acetate

 #6
20190202857
2019-07-04

3-(4'-SUBSTITUTED)-BENZYL-ETHER DERIVATIVES OF PREGNENOLONE

 #7
20190137507
2019-05-09

Quantitative profiling of progesterone metabolites for the prediction of spontaneous preterm delivery

 #8
20190127413
2019-05-02

Compositions and Methods for Non-Toxic Delivery of Antiprogestins

 #9
20190071465
2019-03-07

ANTAGONISTS OF CB1 RECEPTOR

 #10
20180340005
2018-11-29

Conjugated Neuroactive Steroid Compositions And Methods Of Use

 #11
20180282366
2018-10-04

Crystalline and amorphous forms of 17-alpha-hydroxyprogesterone caproate

 #12
20170226148
2017-08-10

3-(4'-SUBSTITUTED)-BENZYL-ETHER DERIVATIVES OF PREGNENOLONE

 #13
20160311849
2016-10-27

Industrial process for the synthesis of ulipristal acetate and its 4′-acetyl analogue

 #14
20160145294
2016-05-26

Antagonists of CB1 receptor

 #15
20150337006
2015-11-26

Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof

 #16
20150284423
2015-10-08

3-(4′-substituted)-benzyl-ether derivatives of pregnenolone

 #17
20150203526
2015-07-23

NOVEL 19-NOR-STEROIDS AND THEIR USE FOR TREATING PROGESTERONE- DEPENDENT CONDITIONS

 #18
20140296510
2014-10-02

Method for preparing ulipristal acetate and key intermediate thereof

 #19
20140200200
2014-07-17

Antagonists of CB1 receptor

 #20
20130274234
2013-10-17

NOVEL 19-NOR-STEROIDS AND THEIR USE FOR TREATING PROGESTERONE- DEPENDENT CONDITIONS

 #21
20130131029
2013-05-23

ANTISOLVENT SOLIDIFICATION PROCESS

 #22
20130018027
2013-01-17

COMPOSITIONS AND METHODS FOR NON-TOXIC DELIVERY OF ANTIPROGESTINS

 #23
20120232296
2012-09-13

ANTISOLVENT SOLIDIFICATION PROCESS

 #24
20110268806
2011-11-03

ANTISOLVENT SOLIDIFICATION PROCESS

 #25
20110040112
2011-02-17

Method for making 3α-hydroxy, 3β- substituted-5α-pregnan-20-ones

 #26
20090318720
2009-12-24

Process for selectively synthesising 3 alpha-hydroxychlormadinone acetate

 #27
20060182808
2006-08-17

Antisolvent solidification process

 #28
20050143365
2005-06-30

Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents